Literature DB >> 30113082

Pathogens and autoimmune hepatitis.

U Christen1, E Hintermann1.   

Abstract

Autoimmune hepatitis (AIH) is a severe form of hepatitis resulting in the autoimmune-mediated destruction of the liver parenchyma. Whereas many of the immunopathogenic events have been elucidated and some of the drivers of the disease have been identified, little is known about the aetiology of the disease. There are certain risk factors, such as particular human leucocyte antigen (HLA) haplotypes, that enhance the susceptibility for AIH or influence the severity of the disease. However, as for many other autoimmune diseases, the mere presence of such risk factors does not warrant the occurrence of the disease. Not all individuals carrying risk factors develop AIH, and not all patients with AIH are carriers of high-risk alleles. Thus, additional environmental factors need to be considered as triggers for AIH. Environmental factors include diet, sunlight exposure, stress, medication and hygiene, as well as pathogen infections and vaccinations. This review discusses if pathogens should be considered as triggers for the initiation and/or propagation of AIH.
© 2018 British Society for Immunology.

Entities:  

Keywords:  CYP2D6; Inflammation; autoimmunity; molecular mimicry; virus infection

Mesh:

Substances:

Year:  2018        PMID: 30113082      PMCID: PMC6300650          DOI: 10.1111/cei.13203

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  130 in total

1.  Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.

Authors:  Edith Hintermann; Janine Ehser; Monika Bayer; Josef M Pfeilschifter; Urs Christen
Journal:  J Autoimmun       Date:  2013-07-01       Impact factor: 7.094

2.  Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.

Authors:  Kalliopi Zachou; Nikolaos Gatselis; Georgia Papadamou; Eirini I Rigopoulou; George N Dalekos
Journal:  J Hepatol       Date:  2011-01-14       Impact factor: 25.083

3.  Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly.

Authors:  K Kojima; R Nagayama; S Hirama; T Maeda; H Takikawa; K Miyake; M Yamanaka; J Shiga
Journal:  J Gastroenterol       Date:  1999-12       Impact factor: 7.527

4.  Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.

Authors:  Edith Hintermann; Martin Holdener; Monika Bayer; Stephanie Loges; Josef M Pfeilschifter; Claude Granier; Michael P Manns; Urs Christen
Journal:  J Autoimmun       Date:  2011-07-26       Impact factor: 7.094

5.  Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.

Authors:  Danilo Villalta; Maria G Mytilinaiou; Martina Elsner; Christian Hentschel; Juliane Cuccato; Valentina Somma; Peter Schierack; Dirk Roggenbuck; Dimitrios P Bogdanos
Journal:  Clin Chim Acta       Date:  2015-07-26       Impact factor: 3.786

6.  Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients.

Authors:  Idriss Djilali-Saiah; Reginald Renous; Sophie Caillat-Zucman; Dominique Debray; Fernando Alvarez
Journal:  J Hepatol       Date:  2004-06       Impact factor: 25.083

7.  Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.

Authors:  Paolo Muratori; Luigi Muratori; Gabriella Verucchi; Luciano Attard; Francesco B Bianchi; Marco Lenzi
Journal:  Clin Infect Dis       Date:  2003-10-13       Impact factor: 9.079

8.  Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection.

Authors:  Megumi Toyoda-Akui; Hiroaki Yokomori; Fumihiko Kaneko; Yuki Shimizu; Hajime Takeuchi; Kumiko Tahara; Hide Yoshida; Hirobumi Kondo; Tadashi Motoori; Makoto Ohbu; Masaya Oda; Toshifumi Hibi
Journal:  Int J Gen Med       Date:  2011-05-24

9.  Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

Authors:  Kalliopi Zachou; Eirini Rigopoulou; George N Dalekos
Journal:  J Autoimmune Dis       Date:  2004-10-15

10.  Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.

Authors:  Martin Holdener; Edith Hintermann; Monika Bayer; Antje Rhode; Evelyn Rodrigo; Gudrun Hintereder; Eric F Johnson; Frank J Gonzalez; Josef Pfeilschifter; Michael P Manns; Matthias von G Herrath; Urs Christen
Journal:  J Exp Med       Date:  2008-05-12       Impact factor: 14.307

View more
  11 in total

1.  May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?

Authors:  Sergey Batskikh; Sergey Morozov; Elena Vinnitskaya; Evgeniya Sbikina; Zanna Borunova; Alexey Dorofeev; Yulia Sandler; Kirill Saliev; Dmitry Kostyushev; Sergey Brezgin; Anastasiya Kostyusheva; Vladimir Chulanov
Journal:  Adv Ther       Date:  2021-11-11       Impact factor: 3.845

2.  Rescue of autoimmune hepatitis by soluble MHC class II molecules in an altered concanavalin A-induced experimental model.

Authors:  Katerina Bakela; Maria Georgia Dimitraki; Evangelia Skoufa; Irene Athanassakis
Journal:  Animal Model Exp Med       Date:  2020-08-27

3.  The Role of Hepatocellular Carcinoma Surveillance in Autoimmune Hepatitis.

Authors:  Ahila Manivannan; Samia Mazumder; Nabil Al-Kourainy
Journal:  Cureus       Date:  2020-10-30

4.  Negative conversion of autoantibody profile in chronic hepatitis B: A case report.

Authors:  Xun Zhang; Qin-Xiu Xie; Dong-Mei Zhao
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

5.  Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.

Authors:  Mei Xue; Yi Shen; Xiaoli Fan; Mengyi Shen; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-04

6.  Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infection.

Authors:  Honglian Gui; Weijing Wang; Qing Li; Ziqiang Li; Jie Lu; Qing Xie
Journal:  Immunol Res       Date:  2021-01-28       Impact factor: 2.829

7.  Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis.

Authors:  Hasan Ali; Taqi Rizvi; Mumtaz Niazi; Mark Galan; Nikolaos Pyrsopoulos
Journal:  J Clin Transl Hepatol       Date:  2021-05-31

Review 8.  Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

Review 9.  Viral Infections and Autoimmune Disease: Roles of LCMV in Delineating Mechanisms of Immune Tolerance.

Authors:  Georgia Fousteri; Amy Dave Jhatakia
Journal:  Viruses       Date:  2019-09-21       Impact factor: 5.048

10.  Frequency of OBI among Patients with Autoimmune Hepatitis.

Authors:  Golnaz Hayat Davoudi; Manoochehr Makvandi; Ali Teimoori; Alireza Samarbafzade; Somayeh Biparva Haghighi; Akbar Bavi; Pezhman Alavinejad; Hossein Keyvani
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.